184 related articles for article (PubMed ID: 7679352)
1. Cyclothiazide reverses AMPA receptor antagonism of the 2,3-benzodiazepine, GYKI 53655.
Palmer AJ; Lodge D
Eur J Pharmacol; 1993 Jan; 244(2):193-4. PubMed ID: 7679352
[TBL] [Abstract][Full Text] [Related]
2. Allosteric interactions between cyclothiazide and AMPA/kainate receptor antagonists.
Yamada KA; Turetsky DM
Br J Pharmacol; 1996 Apr; 117(8):1663-72. PubMed ID: 8732274
[TBL] [Abstract][Full Text] [Related]
3. Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices.
Pittaluga A; Bonfanti A; Arvigo D; Raiteri M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):272-9. PubMed ID: 10344525
[TBL] [Abstract][Full Text] [Related]
4. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466).
Parsons CG; Gruner R; Rozental J
Neuropharmacology; 1994 May; 33(5):589-604. PubMed ID: 7523977
[TBL] [Abstract][Full Text] [Related]
5. Allosteric regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines.
Donevan SD; Rogawski MA
Neuroscience; 1998 Dec; 87(3):615-29. PubMed ID: 9758228
[TBL] [Abstract][Full Text] [Related]
6. Competitive antagonism of recombinant AMPA/kainate receptors by N-methyl-D-aspartate and analogues.
Magazanik LG; Usherwood PN
Neuroreport; 1996 Dec; 8(1):257-9. PubMed ID: 9051791
[TBL] [Abstract][Full Text] [Related]
7. Effects of decahydroisoquinoline-3-carboxylic acid monohydrate, a novel AMPA receptor antagonist, on glutamate-induced CA2+ responses and neurotoxicity in rat cortical and cerebellar granule neurons.
Liljequist S; Cebers G; Kalda A
Biochem Pharmacol; 1995 Nov; 50(11):1761-74. PubMed ID: 8615854
[TBL] [Abstract][Full Text] [Related]
8. The glutamate receptor/NO/cyclic GMP pathway in the hippocampus of freely moving rats: modulation by cyclothiazide, interaction with GABA and the behavioural consequences.
Fedele E; Conti A; Raiteri M
Neuropharmacology; 1997 Oct; 36(10):1393-403. PubMed ID: 9423927
[TBL] [Abstract][Full Text] [Related]
9. Cyclothiazide and AMPA receptor desensitization: analyses from studies of AMPA-induced release of [3H]-noradrenaline from hippocampal slices.
Cowen MS; Beart PM
Br J Pharmacol; 1998 Feb; 123(3):473-80. PubMed ID: 9504388
[TBL] [Abstract][Full Text] [Related]
10. Blocking the trigeminal EPSP in rat abducens motoneurons in vivo with the AMPA antagonists NBQX and GYKI 53655.
Ruiz A; Durand J
Brain Res Bull; 2000 May; 52(2):99-107. PubMed ID: 10808079
[TBL] [Abstract][Full Text] [Related]
11. Interactions of GYKI 52466 and NBQX with cyclothiazide at AMPA receptors: experiments with outside-out patches and EPSCs in hippocampal neurones.
Rammes G; Swandulla D; Spielmanns P; Parsons CG
Neuropharmacology; 1998; 37(10-11):1299-320. PubMed ID: 9849667
[TBL] [Abstract][Full Text] [Related]
12. (S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide: (S18986-1) a positive modulator of AMPA receptors enhances (S)-AMPA-mediated [3H]noradrenaline release from rat hippocampal and frontal cortex slices.
Lockhart B; Iop F; Closier M; Lestage P
Eur J Pharmacol; 2000 Aug; 401(2):145-53. PubMed ID: 10924919
[TBL] [Abstract][Full Text] [Related]
13. Ca2+-permeable non-NMDA glutamate receptors in rat magnocellular basal forebrain neurones.
Waters DJ; Allen TG
J Physiol; 1998 Apr; 508 ( Pt 2)(Pt 2):453-69. PubMed ID: 9508809
[TBL] [Abstract][Full Text] [Related]
14. Characterization of YM90K, a selective and potent antagonist of AMPA receptors, in rat cortical mRNA-injected Xenopus oocytes.
Okada M; Kohara A; Yamaguchi T
Eur J Pharmacol; 1996 Aug; 309(3):299-306. PubMed ID: 8874154
[TBL] [Abstract][Full Text] [Related]
15. Cyclothiazide modulates AMPA receptor-mediated increases in intracellular free Ca2+ and Mg2+ in cultured neurons from rat brain.
Hoyt KR; Rajdev S; Fattman CL; Reynolds IJ
J Neurochem; 1995 May; 64(5):2049-56. PubMed ID: 7536804
[TBL] [Abstract][Full Text] [Related]
16. Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists.
Desai MA; Burnett JP; Ornstein PL; Schoepp DD
J Pharmacol Exp Ther; 1995 Jan; 272(1):38-43. PubMed ID: 7529311
[TBL] [Abstract][Full Text] [Related]
17. Properties of AMPA receptors expressed in rat cerebellar granule cell cultures: Ca2+ influx studies.
Hack N; Balázs R
J Neurochem; 1995 Sep; 65(3):1077-84. PubMed ID: 7543928
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of non-NMDA subtypes of glutamate receptor in the neonatal rat hemisected spinal cord in vitro.
Zeman S; Lodge D
Br J Pharmacol; 1992 Jun; 106(2):367-72. PubMed ID: 1382781
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of noradrenaline release in human cerebral cortex mediated by N-methyl-D-aspartate (NMDA) and non-NMDA receptors.
Fink K; Schultheiss R; Göthert M
Br J Pharmacol; 1992 May; 106(1):67-72. PubMed ID: 1380384
[TBL] [Abstract][Full Text] [Related]
20. Stereoselective neuroprotection by novel 2,3-benzodiazepine non-competitive AMPA antagonist against non-NMDA receptor-mediated excitotoxicity in primary rat hippocampal cultures.
May PC; Robison PM; Fuson KS
Neurosci Lett; 1999 Mar; 262(3):219-21. PubMed ID: 10218895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
